Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 35,910Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 5SANOFI AVENTIS US

02 3ACCORD HLTHCARE

03 2ACTAVIS

04 2ACTAVIS TOTOWA

05 2AM REGENT

06 2CHARTWELL MOLECULAR

07 2EUGIA PHARMA

08 2FRESENIUS KABI ONCOL

09 7FRESENIUS KABI USA

10 3GLAND

11 2GLAND PHARMA LTD

12 2HENGRUI PHARMA

13 2HETERO LABS LTD VI

14 2HOSPIRA INC

15 2HOSPIRA WORLDWIDE

16 2MEITHEAL

17 1MUSTAFA NEVSAT IIAC SANAYII A.S.

18 3MYLAN LABS LTD

19 2NORVIUM BIOSCIENCE

20 2NOVAST LABS

21 1PLIVA LACHEMA

22 5QILU PHARM HAINAN

23 6SANDOZ

24 5SUN PHARM

25 2TEVA PHARMS

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

RLD : Yes

TE Code :

OXALIPLATIN

Brand Name : ELOXATIN

Dosage Form : INJECTABLE;INTRAVENOUS

Dosage Strength : 50MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date : 2002-08-09

Application Number : 21492

RX/OTC/DISCN : DISCN

RLD : Yes

TE Code :

Sanofi Company Banner

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

RLD : Yes

TE Code :

OXALIPLATIN

Brand Name : ELOXATIN

Dosage Form : INJECTABLE;INTRAVENOUS

Dosage Strength : 100MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date : 2002-08-09

Application Number : 21492

RX/OTC/DISCN : DISCN

RLD : Yes

TE Code :

Sanofi Company Banner

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

RLD : Yes

TE Code :

OXALIPLATIN

Brand Name : ELOXATIN

Dosage Form : INJECTABLE;INTRAVENOUS

Dosage Strength : 50MG/10ML (5MG/ML)

Approval Date : 2005-01-31

Application Number : 21759

RX/OTC/DISCN : DISCN

RLD : Yes

TE Code :

Sanofi Company Banner

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

RLD : Yes

TE Code :

OXALIPLATIN

Brand Name : ELOXATIN

Dosage Form : INJECTABLE;INTRAVENOUS

Dosage Strength : 100MG/20ML (5MG/ML)

Approval Date : 2005-01-31

Application Number : 21759

RX/OTC/DISCN : DISCN

RLD : Yes

TE Code :

Sanofi Company Banner

05

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

RLD : Yes

TE Code :

OXALIPLATIN

Brand Name : ELOXATIN

Dosage Form : INJECTABLE;INTRAVENOUS

Dosage Strength : 200MG/40ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date : 2006-11-17

Application Number : 21759

RX/OTC/DISCN : DISCN

RLD : Yes

TE Code :

Sanofi Company Banner

06

Conjugates Summit
Not Confirmed
arrow
arrow
Conjugates Summit
Not Confirmed

OXALIPLATIN

Brand Name : OXALIPLATIN

Dosage Form : INJECTABLE;INTRAVENOUS

Dosage Strength : 50MG/VIAL

Approval Date : 2012-08-08

Application Number : 78803

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

blank

07

Conjugates Summit
Not Confirmed
arrow
arrow
Conjugates Summit
Not Confirmed

OXALIPLATIN

Brand Name : OXALIPLATIN

Dosage Form : INJECTABLE;INTRAVENOUS

Dosage Strength : 100MG/VIAL

Approval Date : 2012-08-08

Application Number : 78803

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

blank

08

Conjugates Summit
Not Confirmed
arrow
arrow
Conjugates Summit
Not Confirmed

OXALIPLATIN

Brand Name : OXALIPLATIN

Dosage Form : INJECTABLE;INTRAVENOUS

Dosage Strength : 50MG/VIAL

Approval Date : 2009-08-07

Application Number : 78810

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

blank

09

Conjugates Summit
Not Confirmed
arrow
arrow
Conjugates Summit
Not Confirmed

OXALIPLATIN

Brand Name : OXALIPLATIN

Dosage Form : INJECTABLE;INTRAVENOUS

Dosage Strength : 50MG/10ML (5MG/ML)

Approval Date : 2009-08-07

Application Number : 22160

RX/OTC/DISCN : RX

RLD : Yes

TE Code : AP

blank

10

Conjugates Summit
Not Confirmed
arrow
arrow
Conjugates Summit
Not Confirmed

OXALIPLATIN

Brand Name : OXALIPLATIN

Dosage Form : INJECTABLE;INTRAVENOUS

Dosage Strength : 100MG/20ML (5MG/ML)

Approval Date : 2009-08-07

Application Number : 22160

RX/OTC/DISCN : RX

RLD : Yes

TE Code : AP

blank